Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Items 101–200 of 898
Progress towards a clinically-successful ATR inhibitor for cancer therapy
Barnieh, F. M., Loadman, P. M., & Falconer, R. A. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100017 · Cited by 142
Skp2 E3 Ligase Integrates ATM Activation and Homologous Recombination Repair by Ubiquitinating NBS1
Wu, J., Zhang, X., Zhang, L., Wu, C., Rezaeian, A. H., Chan, C., Li, J.-M., Wang, J., Gao, Y., Han, F., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.018 · Cited by 147
Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion
Leman, A. R., Noguchi, C., Lee, C. Y., & Noguchi, E. (2010) · Journal of Cell Science · doi:10.1242/jcs.057984 · Cited by 135
Williamson, C. T., Kubota, E., Hamill, J. D., Klimowicz, A. C., Ye, R., Muzik, H., Dean, M. L., Tu, L., Gilley, D. P., Magliocco, A. M., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200229 · Cited by 139
Replication fork dynamics and the DNA damage response
Jones, R. M., & Petermann, E. (2012) · Biochemical Journal · doi:10.1042/bj20112100 · Cited by 160
Woodbine, L., Brunton, H., Goodarzi, A. A., Shibata, A., & Jeggo, P. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr331 · Cited by 129
The Tumor-Immune Microenvironment and Response to Radiation Therapy
Shiao, S. L., & Coussens, L. M. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9194-9 · Cited by 125
Yin, H., & Glass, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024080 · Cited by 135
New agents on the horizon in gastric cancer
Lordick, F., Shitara, K., & Janjigian, Y. Y. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx051 · Cited by 131
Kubota, E., Williamson, C. T., Ye, R., Elegbede, A., Peterson, L., Lees-Miller, S. P., & Bebb, D. G. (2014) · Cell Cycle · doi:10.4161/cc.29212 · Cited by 124
Chromatin remodeling finds its place in the DNA double-strand break response
Pandita, T. K., & Richardson, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1071 · Cited by 122
Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response
Ragu, S., Matos-Rodrigues, G. E., & López, B. S. (2020) · Genes · doi:10.3390/genes11040409 · Cited by 142
Wiltshire, T. D., Lovejoy, C. A., Wang, T., Xia, F., O'Connor, M. J., & Cortez, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104745 · Cited by 123
Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose Homeostasis
Armata, H. L., Golebiowski, D., Jung, D. Y., Ko, H. J., Kim, J. K., & Sluss, H. K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00347-10 · Cited by 119
“Patients can develop a constellation of clinical pathologies, including neuronal degeneration, an elevated risk of cancer, telangiectasias, accelerated aging, growth retardation, and pulmonary disease (25).”
Targeting DNA repair mechanisms in cancer
Furgason, J. M., & Bahassi, E. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.009 · Cited by 136
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
Bisso, A., Faleschini, M., Zampa, F., Capaci, V., Santa, J. D., Santarpia, L., Piazza, S., Cappelletti, V., Daidone, M. G., Agami, R., et al. (2013) · Cell Cycle · doi:10.4161/cc.24757 · Cited by 131
Skowrońska, A., Parker, A. E., Ahmed, G., Oldreive, C., Davis, Z. A., Richards, S. M., Dyer, M. J. S., Matutes, E., Gonzalez, D., Taylor, A. M. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0852 · Cited by 143
SV40 DNA replication: From the A gene to a nanomachine
Fanning, E., & Zhao, K. (2008) · Virology · doi:10.1016/j.virol.2008.11.038 · Cited by 123
ATM protein kinase: the linchpin of cellular defenses to stress
Bhatti, S., Kozlov, S., Farooqi, A. A., Naqi, A., Lavin, M., & Khanna, K. K. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0683-9 · Cited by 116
Self-citationPredictive biomarkers for cancer therapy with PARP inhibitors
Michels, J., Vitale, I., Saparbaev, M. K., Castedo, M., & Kroemer, G. (2013) · Oncogene · doi:10.1038/onc.2013.352 · Cited by 124
ATM Regulates a RASSF1A-Dependent DNA Damage Response
Hamilton, G., Yee, K. S. Y., Scrace, S., & O’Neill, E. E. (2009) · Current Biology · doi:10.1016/j.cub.2009.10.040 · Cited by 118
Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice
Yamamoto, K., Wang, Y., Jiang, W., Liu, X., Dubois, R. L., Lin, C.-S., Ludwig, T., Bakkenist, C. J., & Zha, S. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201204098 · Cited by 113
Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing
Shiloh, Y., & Lederman, H. M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.002 · Cited by 121
Rejuvenating the immune system in rheumatoid arthritis.
Weyand, C. M., Fujii, H., Shao, L., & Goronzy, J. J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.180 · Cited by 112
Yang, C., Tang, X., Guo, X., Niikura, Y., Kitagawa, K., Cui, K., Wong, S. T. C., Fu, L., & Xu, B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.016 · Cited by 130
Activation of the ATM-Snail pathway promotes breast cancer metastasis
Sun, M., Guo, X., Qian, X., Wang, H., Yang, C., Brinkman, K. L., Serrano-Gonzalez, M., Jope, R. S., Zhou, B., Engler, D. A., et al. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs048 · Cited by 112
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
Wang, W., Mani, A. M., & Wu, Z.-H. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.03 · Cited by 104
Telomeres and immunological diseases of aging.
Andrews, N. P., Fujii, H., Goronzy, J. J., & Weyand, C. M. (2010) · Gerontology · doi:10.1159/000268620 · Cited by 108
The Heterochromatic Barrier to DNA Double Strand Break Repair: How to Get the Entry Visa
Goodarzi, A. A., & Jeggo, P. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911844 · Cited by 108
ATM specifically mediates repair of double-strand breaks with blocked DNA ends
Álvarez-Quilón, A., Serrano-Benítez, A., Lieberman, J. A., Quintero, C., Sánchez‐Gutiérrez, D., Escudero, L. M., & Cortés‐Ledesma, F. (2014) · Nature Communications · doi:10.1038/ncomms4347 · Cited by 129
Chfr and RNF8 synergistically regulate ATM activation
Wu, J., Chen, Y., Lu, L.-Y., Wu, Y., Paulsen, M. T., Ljungman, M., Ferguson, D. O., & Yu, X. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2078 · Cited by 107
“1 38 T (2; 1) T (12; 15) T (12; 16) T (17; 14) 2 39 T (10; 1) T (12; 16) T (12; 1) T (6; 7) 3 40 T (13; 12) T (14; 12) T (12; 1) T (3; 15) 4 40 T (14; 3) T (13; 12) T (19; X) 5 39 T (2; 1) T (12; 15) T (12; 16) T (17; 6) Karyotypes of T-cell lymphomas Tumor”
ATM: Expanding roles as a chief guardian of genome stability
Shiloh, Y. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.002 · Cited by 118
Pallardó, F. V., Lloret, A., Lebel, M., d’Ischia, M., Cogger, V. C., Couteur, D. G. L., Gadaleta, M. N., Castello, G., & Pagano, G. (2010) · Biogerontology · doi:10.1007/s10522-010-9269-4 · Cited by 116
Loss of ATM kinase activity leads to embryonic lethality in mice
Daniel, J. A., Pellegrini, M., Lee, B.-S., Guo, Z., Filsuf, D., Belkina, N. V., You, Z., Paull, T. T., Sleckman, B. P., Feigenbaum, L., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201204035 · Cited by 108
Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability
Dorstyn, L., Puccini, J., Wilson, C. H., Shalini, S., Nicola, M., Moore, S., & Kumar, S. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.36 · Cited by 104
Golding, S. E., Rosenberg, E., Adams, B. R., Wignarajah, S., Beckta, J. M., O’Connor, M. J., & Valerie, K. C. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19576 · Cited by 121
A mammalian functional-genetic approach to characterizing cancer therapeutics
Jiang, H., Pritchard, J. R., Williams, R. T., Lauffenburger, D. A., & Hemann, M. T. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.503 · Cited by 106
Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS
Shull, E. R. P., Lee, Y., Nakane, H., Stracker, T. H., Zhao, J., Russell, H. R., Petrini, J. H. J., & McKinnon, P. J. (2009) · Genes & Development · doi:10.1101/gad.1746609 · Cited by 106
Reeves, R. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.09.015 · Cited by 119
The Genomics of Lung Adenocarcinoma: Opportunities for Targeted Therapies
Greulich, H. E. (2010) · Genes & Cancer · doi:10.1177/1947601911407324 · Cited by 118
Transgenic Animal Models in Toxicology: Historical Perspectives and Future Outlook
Boverhof, D. R., Chamberlain, M. P., Elcombe, C. R., Gonzalez, F. J., Heflich, R. H., Hernández, L. G., Jacobs, A. C., Jacobson-Kram, D., Luijten, M., Maggi, A., et al. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr075 · Cited by 103
Xu, H., Balakrishnan, K., Malaterre, J., Beasley, M. D., Yan, Y., Essers, J., Appeldoorn, E., Thomaszewski, J. M., Vazquez, M., Verschoor, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012112 · Cited by 122
Self-citationRenner, F., Moreno, R., & Schmitz, M. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.018 · Cited by 104
Luthra, P., Aguirre, S., Yen, B. C., Pietzsch, C. A., Sanchez-Aparicio, M. T., Tigabu, B., Morlock, L. K., García-Sastre, A., Leung, D. W., Williams, N. S., et al. (2017) · mBio · doi:10.1128/mbio.00368-17 · Cited by 96
Mre11: roles in DNA repair beyond homologous recombination
Zha, S., Boboilă, C., & Alt, F. W. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0809-798 · Cited by 122
ATM prevents DSB formation by coordinating SSB repair and cell cycle progression
Khoronenkova, S. V., & Dianov, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416031112 · Cited by 111
Kerzendorfer, C., & O’Driscoll, M. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.018 · Cited by 97
Zhan, H., Suzuki, T., Aizawa, K., Miyagawa, K., & Nagai, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125138 · Cited by 96
Transcriptional modulation induced by ionizing radiation: p53 remains a central player
Rashi‐Elkeles, S., Elkon, R., Shavit, S., Lerenthal, Y., Linhart, C., Kupershtein, A., Amariglio, N., Rechavi, G., Shamir, R., & Shiloh, Y. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.06.004 · Cited by 95
The German National Registry of Primary Immunodeficiencies (2012–2017)
El-Helou, S. M., Biegner, A.-K., Bode, S. F. N., Ehl, S. R., Heeg, M., Maccari, M. E., Ritterbusch, H., Speckmann, C., Rusch, S., Scheible, R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01272 · Cited by 108
CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle
Dent, P., Tang, Y., Yacoub, A., Dai, Y., Fisher, P. B., & Grant, S. (2011) · Molecular Interventions · doi:10.1124/mi.11.2.11 · Cited by 100
Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer
Annunziata, C. M., & O’Shaughnessy, J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0526 · Cited by 106
53BP1-mediated DNA double strand break repair: Insert bad pun here
Noon, A. T., & Goodarzi, A. A. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.07.012 · Cited by 111
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
Gilardini Montani, M. S., Prodosmo, A., Stagni, V., Merli, D., Monteonofrio, L., Gatti, V., Gentileschi, M. P., Barilà, D., & Soddu, S. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-95 · Cited by 94
Mammalian TIMELESS Is Required for ATM-dependent CHK2 Activation and G2/M Checkpoint Control
Yang, X., Wood, P. A., & Hrushesky, W. J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050237 · Cited by 106
The cell cycle checkpoint inhibitors in the treatment of leukemias
Ghelli Luserna di Rora’, A., Iacobucci, I., & Martinelli, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0443-x · Cited by 93
Petsalaki, E., & Zachos, G. (2020) · FEBS Journal · doi:10.1111/febs.15240 · Cited by 103
Low‐dose radiation may be a novel approach to enhance the effectiveness of cancer therapeutics
Yang, G., Li, W., Jiang, H., Liang, X., Zhao, Y., Yu, D., Zhou, L., Wang, G., Tian, H., Han, F., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30235 · Cited by 94
Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene
Hsu, F.-C., Roberts, N. J., Childs, E., Porter, N., Rabe, K. G., Borgida, A., Ukaegbu, C., Goggins, M. G., Hruban, R. H., Zogopoulos, G., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3701 · Cited by 91
ATM Protein-dependent Phosphorylation of Rad50 Protein Regulates DNA Repair and Cell Cycle Control
Gatei, M. H., Jakob, B., Chen, P., Kijas, A. W., Bécherel, O. J., Gueven, N., Birrell, G. W., Lee, J., Paull, T. T., Lerenthal, Y., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258152 · Cited by 109
Self-citationLim, Y. C., Roberts, T. L., Day, B. W., Harding, A. S., Kozlov, S., Kijas, A. W., Ensbey, K. S., Walker, D., & Lavin, M. F. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-1044 · Cited by 104
“Failure to observe normal radiation signaling through SMC1, Chk1, and Chk2 in U87 can be explained by reduced protein levels.”
InfluentialSelf-citationHigh mobility group protein-mediated transcription requires DNA damage marker γ-H2AX
Singh, I., Öztürk, N., Cordero, J., Mehta, A., Hasan, D., Cosentino, C., Sebastián, C., Krüger, M., Looso, M., Carraro, G., et al. (2015) · Cell Research · doi:10.1038/cr.2015.67 · Cited by 96
Kozlov, S. V., Waardenberg, A. J., Engholm-Keller, K., Arthur, J. W., Graham, M. E., & Lavin, M. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.055723 · Cited by 90
Self-citationGreen, A. M., & Kupfer, G. M. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.008 · Cited by 114
DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis
Enriquez-Rios, V., Dumitrache, L. C., Downing, S. M., Li, Y., Brown, E. J., Russell, H. R., & McKinnon, P. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.4213-15.2016 · Cited by 88
Amirifar, P., Ranjouri, M. R., Lavin, M. F., Abolhassani, H., Yazdani, R., & Aghamohammadi, A. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1810570 · Cited by 99
Self-citationKim, H., Saka, B., Knight, S., Borges, M., Childs, E., Klein, A., Wolfgang, C., Herman, J., Adsay, V. N., Hruban, R. H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1239 · Cited by 85
Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis
Seif, A. E. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.04.005 · Cited by 99
Liu, X., Jiang, W., Dubois, R. L., Yamamoto, K., Wolner, Z. J., & Zha, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120160109 · Cited by 97
New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress
Chen, B. P. C., Li, M., & Asaithamby, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.004 · Cited by 84
Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., Vellon, L., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100407 · Cited by 85
“In response to oxidative stress, ATM is phosphorylated at Ser-1981, which results in phosphorylation of its substrates, including p53, the master controller of DNA metabolic stresses, and AMP-activated protein kinase-α (AMPKα), the key sensor of fuel and energy status [6, 7].”
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond
Markkanen, E., Meyer, U., & Dianov, G. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060856 · Cited by 89
Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage
Bačević, K., Lossaint, G., Achour, T. N., Georget, V., Fisher, D., & Dulić, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-12868-5 · Cited by 99
Bohgaki, T., Bohgaki, M., Cardoso, R., Panier, S., Zeegers, D., Li, L., Stewart, G. S., Sanchez, O., Hande, M. P., Durocher, D., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001381 · Cited by 83
DNA double-strand break signaling and human disorders
Bohgaki, T., Bohgaki, M., & Hakem, R. (2010) · Genome Integrity · doi:10.1186/2041-9414-1-15 · Cited by 118
Lossaint, G., Besnard, E., Fisher, D., Piette, J., & Dulić, V (2011) · Oncogene · doi:10.1038/onc.2011.135 · Cited by 83
SUMOylation and de‐SUMOylation in response to DNA damage
Dou, H., Huang, C., Nguyen, T. V., Lu, L., & Yeh, E. T. H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.002 · Cited by 96
ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification
Zha, S., Bassing, C. H., Sanda, T., Brush, J. W., Patel, H., Goff, P. H., Murphy, M. M., Tepsuporn, S., Gatti, R. A., Look, A. T., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100285 · Cited by 86
Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Importance of DNA damage checkpoints in the pathogenesis of human cancers
Poehlmann, A., & Roessner, A. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.06.006 · Cited by 99
Targeting ATR in cancer medicine
Sundar, R., Brown, J. S., Garces, A. I., & Yap, T. A. (2017) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2017.05.002 · Cited by 85
Thyrotropin releasing hormone (TRH): a new player in human hair‐growth control
Gáspár, E., Hardenbicker, C., Bodó, E., Wenzel, B. E., Ramot, Y., Funk, W., Kromminga, A., & Paus, R. (2009) · The FASEB Journal · doi:10.1096/fj.08-126417 · Cited by 85
Genomic instability and the selection of treatments for cancer
Martin, S. A., Hewish, M., Lord, C. J., & Ashworth, A. (2010) · The Journal of Pathology · doi:10.1002/path.2631 · Cited by 82
A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype
Quek, H., Luff, J., Cheung, K., Kozlov, S., Gatei, M., Lee, C. S., Bellingham, M. C., Noakes, P. G., Lim, Y. C., Barnett, N. L., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw371 · Cited by 81
Self-citationThe Limitations of the G1-S Checkpoint
Deckbar, D., Stiff, T., Koch, B., Reis, C., Löbrich, M., & Jeggo, P. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3198 · Cited by 92
Cataldo, A., Cheung, D. G., Balsari, A., Tagliabue, E., Coppola, V., Iorio, M. V., Palmieri, D., & Croce, C. M. (2015) · Oncotarget · doi:10.18632/oncotarget.6381 · Cited by 81
Efficacy of very-low-dose betamethasone on neurological symptoms in ataxia-telangiectasia
Broccoletti, T., Giudice, E. D., Cirillo, E., Vigliano, I., Giardino, G., Ginocchio, V. M., Bruscoli, S., Riccardi, C., & Pignata, C. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03203.x · Cited by 81
Lai, J.-M., Chang, J. T., Wen, C.-L., & Hsu, S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.031 · Cited by 80
Liu, R.-L., Dong, Y., Deng, Y.-Z., Wang, W., & Li, W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3152-5 · Cited by 77
ATR maintains select progenitors during nervous system development
Lee, Y., Shull, E. R., Frappart, P., Katyal, S., Enriquez‐Rios, V., Zhao, J., Russell, H. R., Brown, E. J., & McKinnon, P. J. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.493 · Cited by 72
Impaired DNA damage response — An Achilles' heel sensitizing cancer to chemotherapy and radiotherapy
Darżynkiewicz, Z., Traganos, F., & Włodkowic, D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.032 · Cited by 86
RNF20–RNF40: A ubiquitin‐driven link between gene expression and the DNA damage response
Shiloh, Y., Shema, E., Moyal, L., & Oren, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.034 · Cited by 83
Chuang, C.-Y., Liu, H.-C., Wu, L.-C., Chen, C.-Y., Chang, J. T., & Hsu, S. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9043265 · Cited by 78
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease
Rodríguez‐Vicente, A. E., Díaz, M. G., & Hernández‐Rivas, J. M. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.01.003 · Cited by 94
Du, L., Kayalı, R., Bertoni, C., Fike, F. M., Hu, H., Iversen, P. L., & Gatti, R. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr217 · Cited by 74
Danger signals: Chemotherapy enhancers?
Rivera Vargas, T., & Apetoh, L. (2017) · Immunological Reviews · doi:10.1111/imr.12581 · Cited by 74
Death by design: where curcumin sensitizes drug-resistant tumours.
Saha, S., Adhikary, A., Bhattacharyya, P., Das, T., & Sa, G. (2012) · PubMed · Cited by 80
Mansour, W. Y., Bogdanova, N. V., Kasten-Pisula, U., Rieckmann, T., Köcher, S., Borgmann, K., Baumann, M. A., Krause, M., Petersen, C., Hu, H., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.020 · Cited by 78
Inherited Mutations in Breast Cancer Genes—Risk and Response
Shuen, A. Y., & Foulkes, W. D. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9213-5 · Cited by 93
The versatile functions of ATM kinase
Xu, B., & Boohaker, R. J. (2014) · Biomedical Journal · doi:10.4103/2319-4170.125655 · Cited by 77
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.